Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2000
03/28/2000US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes
03/28/2000US6043273 Compositions, apparatus and methods for facilitating surgical procedures
03/28/2000US6043265 Isoxazolyl endothelin antagonists
03/28/2000US6043263 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
03/28/2000US6043261 Pyrrolodino imidines useful as nitric oxide synthase inhibitors
03/28/2000US6043260 Method of treating heart failure
03/28/2000US6043259 Treatment of cardiovascular and related pathologies
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6042847 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
03/28/2000CA2126086C Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
03/28/2000CA2109625C 3,5,3'-triiodothyronine receptor ligands
03/28/2000CA2014453C Adamantane-derivatives in the prevention and treatment of cerebral ischemia
03/23/2000WO2000015821A1 Recombinant adenovirus for tissue specific expression in heart
03/23/2000WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015783A2 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO β1-ADRENOCEPTOR-SPECIFIC mRNA AND METHODS OF USE
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015658A1 FACTOR VIIa INHIBITORS
03/23/2000WO2000015649A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015609A1 Azetidine derivatives, preparation and medicines containing them
03/23/2000WO2000015261A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use
03/23/2000WO2000015258A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000WO2000015244A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
03/23/2000WO2000015237A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000015231A1 Adenosine a3 receptor modulators
03/23/2000WO2000015230A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015229A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015216A1 Therapeutic compositions (ii)
03/23/2000WO2000015215A1 Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF
03/23/2000WO2000015206A2 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
03/23/2000WO2000015204A2 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers
03/23/2000WO2000015198A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000WO2000015047A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000WO2000015044A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000008013A3 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
03/23/2000WO2000000599A3 Composition for the induction of apoptosis in target cells
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000WO1999046316A3 Enzyme inhibitors
03/23/2000WO1998015272A8 Method for inhibiting stress-activated protein kinases
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000DE19843489A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors, useful for treatment of ischemia and other circulation disorders, tumors, prostatic hypertrophy and diabetic complications
03/23/2000DE19842415A1 Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor
03/23/2000CA2344401A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2344322A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000CA2344309A1 Method for treating diabetes employing an ap2 inhibitor and combination
03/23/2000CA2344300A1 Method for treating atherosclerosis employing an ap2 inhibitor and combination
03/23/2000CA2344151A1 Pharmaceutical preparation
03/23/2000CA2344054A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2344048A1 Factor viia inhibitors
03/23/2000CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2343220A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2341440A1 Novel compounds
03/23/2000CA2339941A1 Use of cyclic esters of r-3-hydroxybutyrate for treatment of metabolic and neural degenerative disorders
03/23/2000CA2339354A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000EP0987274A1 Factor VIIa Inhibitors
03/22/2000EP0987254A1 Novel cyclic diamine compounds and medicine containing the same
03/22/2000EP0987253A1 Pyrazolone derivatives
03/22/2000EP0987251A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors
03/22/2000EP0986963A2 Stable, powdery lycopene formulations containing lycopene with a degree of crystallisation of more than 20%
03/22/2000EP0986580A1 Oligosaccharide mixtures having antithrombotic activity
03/22/2000EP0986552A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
03/22/2000EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
03/22/2000EP0986537A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986392A1 Method of treating chronic progressive vascular scarring diseases
03/22/2000EP0986390A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
03/22/2000EP0986384A1 Inhibitors of protein isoprenyl transferases
03/22/2000EP0986376A1 COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT
03/22/2000EP0790997B1 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
03/22/2000CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells
03/22/2000CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
03/22/2000CN1248254A Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for treatment of neurodegenerative and CNS-trauma related conditions
03/22/2000CN1248251A Disubstituted bicyclic heterocycles, their production and use as medicaments
03/22/2000CN1248177A Coated particles, method of making and using
03/22/2000CN1248170A Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor
03/22/2000CN1248162A Topical pharmaceutical composition comprising cholinergic agent or calcium channel blocker
03/22/2000CN1247760A Heart disease treating medicine
03/22/2000CN1247759A Hemiplegia treating pill
03/22/2000CN1247749A Medicine liquid capable of activating blood circulation to dissipate blood stasis, nourishing Yin, protecting Yang and treating soft tissue injury
03/22/2000CN1050605C Cycloalkano-indole and -azaindole derivatives, its prepn. and medical composition containing them
03/21/2000US6040451 Used as analgesic, sedative and anaesthetic agents
03/21/2000US6040444 Process for preparing furan nitrone compounds
03/21/2000US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal
03/21/2000US6040337 5-demethoxyfumagillol derivatives and processes for preparing the same
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040322 Medicaments for ameliorating endothelial cell activation
1 ... 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 ... 1595